Denmark suspended the usage of the AstraZeneca vaccine due to issues about hyperlinks to an elevated threat of blood clots, the Danish Well being Authority introduced on Thursday.
All use of the vaccine is now halted for at the least 14 days after a number of extreme instances of clots had been reported amongst individuals who had obtained the shot, the nationwide broadcaster DR reported.
The Danish Medicines Company mentioned in an announcement that it was investigating the loss of life of an individual vaccinated with the AstraZeneca shot who developed a blood clot.
The Danish minister of well being, Magnus Heunicke, posted a message on Twitter confirming that the usage of the AstraZeneca vaccine had been suspended, “following a sign of attainable critical negative effects within the type of deadly blood clots.”
“It’s presently not attainable to conclude whether or not there’s a connection,” he added. “We acted early, it must be completely investigated.”
A complete of simply over 142,000 individuals in Denmark, which has a inhabitants of about six million, have been injected with the vaccine produced by AstraZeneca, a British-Swedish firm.
As of Feb. 28, Britain had administered 9.7 million doses of the AstraZeneca vaccine. The British medication watchdog, the Medicines and Healthcare Merchandise Regulatory Company, has not publicly outlined any issues about blood clots. “The quantity and nature of suspected antagonistic reactions reported up to now will not be uncommon compared to different sorts of routinely used vaccines,” the company mentioned.
Within the assertion from the Danish Medicines Company, Tanja Erichsen, a divisional director, mentioned, “We don’t but know whether or not the blood clots and the Danish loss of life is attributable to the vaccine, however it’s being completely investigated proper now to be on the protected facet.”
The Danish Well being Authority pointed to a number of such instances reported throughout Europe and mentioned that it will await additional investigation by the European Medicines Company, the drug regulatory physique for the European Union.
On Wednesday, the European company mentioned there was no indication that two Austrian instances — one through which a affected person died after blood clots shaped and one other through which a affected person was hospitalized with an identical situation — had been associated to the usage of the vaccine.
Using the precise batch of the vaccine that led to the instances in Austria was suspended within the nation, and subsequently additionally in Estonia, Latvia, Lithuania and Luxembourg. The European Medicines Company mentioned a high quality defect was “unlikely” however mentioned that the batch can be investigated additional.
Soren Brostrom, director of the Nationwide Board of Well being in Denmark, mentioned: “We’re in the midst of the biggest and most essential vaccination rollout in Danish historical past. And proper now we want all of the vaccines we will get. Subsequently, placing one of many vaccines on pause isn’t a simple resolution.”
“However exactly as a result of we vaccinate so many,” he added, “we additionally want to reply with well timed care when there may be information of attainable critical negative effects.”
Jasmina Nielsen and Benjamin Mueller contributed reporting.